Jeyam, AnitaGibb, Fraser WMcKnight, John AKennon, BrianO'Reilly, Joseph ECaparrotta, Thomas MHöhn, AndreasMcGurnaghan, Stuart JBlackbourn, Luke A KHatam, SaraMcCrimmon, Rory JLeese, GrahamLindsay, Robert SPetrie, JohnChalmers, JohnPhilip, SamWild, Sarah HSattar, NaveedMcKeigue, Paul MColhoun, Helen MScottish Diabetes Research Network (SDRN) Epidemiology group2021-12-212021-12-212021-06-01Jeyam, A, Gibb, F W, McKnight, J A, Kennon, B, O'Reilly, J E, Caparrotta, T M, Höhn, A, McGurnaghan, S J, Blackbourn, L A K, Hatam, S, McCrimmon, R J, Leese, G, Lindsay, R S, Petrie, J, Chalmers, J, Philip, S, Wild, S H, Sattar, N, McKeigue, P M, Colhoun, H M & Scottish Diabetes Research Network (SDRN) Epidemiology group 2021, 'Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes : a nationwide observational study in Scotland', Diabetologia, vol. 64, no. 6, pp. 1320-1331. https://doi.org/10.1007/s00125-021-05413-70012-186XPubMedCentral: PMC8099793ORCID: /0000-0001-6164-211X/work/105177160https://hdl.handle.net/2164/17733Acknowledgements We thank the SDRN Epidemiology Group: J. Chalmers (Diabetes Centre, Victoria Hospital, Kirkcaldy, UK), C. Fischbacher (Information Services Division, NHS National Services Scotland, Edinburgh, UK), B. Kennon (Queen Elizabeth University Hospital, Glasgow, UK), G. Leese (Ninewells Hospital, Dundee, UK), R. Lindsay (British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK), J. McKnight (Western General Hospital, NHS Lothian, Edinburgh, UK), J. Petrie (Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, UK), R. McCrimmon (Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK), S. Philip (Grampian Diabetes Research Unit, Diabetes Centre, Aberdeen Royal Infirmary, Aberdeen, UK), D. McAllister (Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK), E. Pearson (Population Health and Genomics, School of Medicine, University of Dundee, Dundee, UK) and S. Wild (Usher Institute, University of Edinburgh, Edinburgh, UK). Some of the data were presented as an abstract (poster presentation) at the 56th EASD Annual Meeting in 2020. Funding This study was supported by funding from Diabetes UK (17/0005627) and the Chief Scientist Office (ref. ETM/47).121002089engSDG 3 - Good Health and Well-beingDiabetes mellitus type 1HbA1cHypoglycaemiaInsulin pumpKetoacidosisR MedicineChief Scientist Office (CSO)ETM/47OtherDiabetes UK (17/0005627)Supplementary InformationRJournal article10.1007/s00125-021-05413-7646